文献速递技术与安全US

腹部低强度脉冲超声治疗减轻糖尿病小鼠肠道损伤和微生物群失调

Abdominal Low-intensity Pulsed Ultrasound Therapy Mitigates Intestinal Damage and Microbial Dysbiosis in Diabetic Mice.
PubMed 文献 · Ultrasound Med Biol · 2025-12-29

本研究在链脲佐菌素诱导的1型糖尿病小鼠中,每日给予20分钟腹部低强度脉冲超声(30 mW/cm²)治疗6周,发现治疗上调肠道紧密连接蛋白ZO-1和Occludin表达、增加有益菌及短链脂肪酸、降低脂多糖,并显著降低血糖,提示腹部低强度脉冲超声可恢复肠道屏障完整性和微生物群稳态。

要点

  • 腹部低强度脉冲超声(30 mW/cm²,每日20分钟,共6周)可上调糖尿病小鼠肠道ZO-1和Occludin的mRNA表达。
  • 治疗增加有益菌(如Lactobacillus、Intestinimonas)丰度及短链脂肪酸(乙酸、丙酸、丁酸)水平,降低脂多糖。
  • 治疗显著降低糖尿病小鼠血糖,为缓解糖尿病进展提供新思路。

核心结论

  • 腹部低强度脉冲超声可恢复肠道屏障完整性和微生物群稳态,是减轻糖尿病进展的一种新治疗策略。

研究设计与样本

  • 动物实验:链脲佐菌素诱导的1型糖尿病小鼠接受每日20分钟腹部低强度脉冲超声(30 mW/cm²)治疗6周,监测体重和血糖,处死后评估肠道形态、屏障完整性、肠道菌群组成及微生物代谢产物。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Diabetes impairs intestinal barrier integrity and disrupts gut microbiota balance, exacerbating hyperglycemia. While low-intensity pulsed ultrasound (LIPUS) has been shown to alleviate inflammatory bowel disease (IBD), its role in diabetes-related gut dysfunction remains unclear. This study aimed to investigate whether LIPUS could improve intestinal barrier function, modulate gut microbiota, and mitigate hyperglycemia in type 1 diabetic (T1D) mice.

METHODS: Streptozotocin-induced type 1 diabetic (T1D) mice received a daily 20-min abdominal LIPUS treatment (30 mW/cm²) for 6 wk. Body weight and blood glucose levels were monitored weekly throughout the intervention period. After sacrifice, the intestinal morphology was examined, and barrier integrity was systematically evaluated. The composition of the gut microbiota was analyzed, along with the quantification of microbial-derived metabolites.

RESULTS: T1D mice exhibited weight loss, hyperglycemia, intestinal damage, and microbial dysbiosis. LIPUS treatment upregulated the intestinal mRNA expression of ZO-1 and Occludin, enhancing barrier function. LIPUS increased the abundance of beneficial bacteria (e.g., Lactobacillus, Intestinimonas) and the levels of short-chain fatty acids (acetate, propionate, butyrate), while reducing lipopolysaccharides. Crucially, LIPUS significantly lowered blood glucose levels in the diabetic mice.

CONCLUSION: These findings demonstrate that abdominal LIPUS restores gut barrier integrity and microbiota homeostasis, offering a novel therapeutic strategy for mitigating the progression of diabetes.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Tang L, Zhang H, Yu Y, et al. Abdominal Low-intensity Pulsed Ultrasound Therapy Mitigates Intestinal Damage and Microbial Dysbiosis in Diabetic Mice. Ultrasound Med Biol. 2025. PMID: 41469263. doi:10.1016/j.ultrasmedbio.2025.11.661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。